{"id":79009,"date":"2026-03-30T12:05:26","date_gmt":"2026-03-30T12:05:26","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/"},"modified":"2026-03-30T12:05:26","modified_gmt":"2026-03-30T12:05:26","slug":"evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/","title":{"rendered":"Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress"},"content":{"rendered":"<div>\n<ul>\n<li style=\"text-align:justify;\"><b>Using its pioneering AI-platform, AI-Immunology&#x2122;, Evaxion has,<\/b> <b>in collaboration with the Gates Foundation, developed novel design concepts for polio vaccines potentially superior to those currently used<\/b><\/li>\n<li style=\"text-align:justify;\"><b>The AI-Immunology&#x2122; concepts include hybrid capsid designs and <\/b><b><i>de novo<\/i><\/b><b> designed B-cell antigen approaches<\/b><\/li>\n<li style=\"text-align:justify;\"><b>Despite polio vaccines being available for decades, the highly infectious viral disease continues to pose a global health risk<\/b><\/li>\n<li style=\"text-align:justify;\"><b>Evaxion will also present data from its EVX-V1 vaccine program targeting cytomegalovirus at the World Vaccine Congress<\/b><\/li>\n<\/ul>\n<p align=\"justify\">COPENHAGEN, Denmark, March 30, 2026 &#8211; Evaxion A\/S (NASDAQ: EVAX) (\u201cEvaxion\u201d), a clinical-stage TechBio company developing novel vaccines with its pioneering AI-Immunology&#x2122; platform, has in collaboration with the Gates Foundation developed novel and potentially superior concepts for design of vaccines to combat polio. These concepts, and the underlying research, will be presented at the World Vaccine Congress taking place in Washington D.C. from March 31 to April 2, 2026.<\/p>\n<p align=\"justify\">Current polio vaccines are based on inactivated or attenuated versions of the virus. While these vaccines are effective, they each have shortcomings in certain settings. Thus, it has been a long-standing &#8211; but so far unreachable &#8211; goal to create a novel polio vaccine that combines the strongest aspects of the existing vaccines.<\/p>\n<p align=\"justify\">To achieve this, Evaxion has deployed AI-Immunology&#x2122; to develop novel vaccine design concepts for a next-generation polio vaccine, which may enhance the chances of completing and sustaining polio eradication once and for all.<\/p>\n<p align=\"justify\">\u201cThese new polio vaccine design concepts are great examples of how AI-Immunology&#x2122; enables novel approaches to diseases for which adequate treatment options do not exist despite decades of research. We are excited to have applied the platform within a new viral disease, further validating its capability and scalability. Initial results support further development of the new concepts, representing another potential collaboration opportunity for us,\u201d says Birgitte R\u00f8n\u00f8, CSO of Evaxion.<\/p>\n<p align=\"justify\">Evaxion will also present data from its EVX-V1 program at the World Vaccine Congress. EVX-V1 targets Cytomegalovirus (CMV). AI-Immunology&#x2122; has discovered novel CMV antigens and EVX-V1 is a next-generation, multi-component vaccine program combining these novel AI-discovered antigens with AI-optimized versions of established CMV vaccine antigens. This broader multi-targeted strategy is expected to strengthen the protective potential of the future vaccine.<\/p>\n<p align=\"justify\"><b>Presentations details:<\/b><br \/>Presentation title: Designing a novel poliovirus vaccine using AI-Immunology&#x2122;<br \/>Session: Emerging &amp; re-emerging diseases<br \/>Location: Room 202A<br \/>Date\/Time: April 1, 2026, at 16:40 ET\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 <br \/>Presenter: Thomas Trolle, PhD, Director, Bioinformatics at Evaxion<\/p>\n<p align=\"justify\">Abstract title: AI-powered target discovery for a novel CMV vaccine<br \/>Session: Emerging &amp; re-emerging Diseases<br \/>Location: Room 202A<br \/>Date\/Time: April 2, 2026, at 10:25 ET<br \/>Presenter: P\u00e4r Comstedt, VP, Infectious disease vaccine development at Evaxion<\/p>\n<p align=\"justify\"><b>Contact information<\/b>\u00a0<br \/>Evaxion A\/S<br \/>Mads Kronborg<br \/>Vice President, Investor Relations &amp; Communication<br \/>+45 53 54 82 96 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=m0Gde4SeuAkB6iECswwDnD-3EFbu_wXe_EDRfD9sQN9MWTRu1ePjGzOynuz41tbxE5MXAx2uY_Uf8kUo-cZO5g==\" rel=\"nofollow\" target=\"_blank\" title=\"mak@evaxion.ai\">mak@evaxion.ai<\/a><\/p>\n<p align=\"justify\"><b>About Evaxion<\/b> <br \/>Evaxion is a pioneering TechBio company based upon its proprietary, clinically validated and scalable AI platform, AI-Immunology&#x2122;. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases.<\/p>\n<p align=\"justify\">With AI-Immunology&#x2122; we conduct rapid, efficient and high-quality target discovery, drug design and development. Our team of +40 experts covers the entire value chain from target discovery to clinical development<\/p>\n<p align=\"justify\">We have developed a clinical pipeline of both personalized and off-the-shelf cancer vaccine candidates as well as prophylactic vaccine candidates for infectious diseases. All our candidates address high unmet medical needs, reflecting our commitment to transforming patients\u2019 lives by providing innovative and targeted treatment options.<\/p>\n<p align=\"justify\">For more information about Evaxion, AI-Immunology&#x2122; and our pipeline, please visit our <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mZRcOCpOElBEje7oh2NEmQOxaB_oMD_JVaBmXBdUOX4e7j8hAPJxMon2Y3oMPw65OvIKWpAFQcTQPZOj0KrjUA==\" rel=\"nofollow\" target=\"_blank\" title=\"website\">website<\/a>.\u00a0<\/p>\n<p align=\"justify\"><b>Forward-looking statement<\/b>\u00a0<br \/>This\u00a0announcement contains forward-looking statements\u00a0within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.\u00a0The words\u00a0\u201ctarget,\u201d \u201cbelieve,\u201d \u201cexpect,\u201d \u201chope,\u201d \u201caim,\u201d \u201cintend,\u201d \u201cmay,\u201d \u201cmight,\u201d \u201canticipate,\u201d \u201ccontemplate,\u201d \u201ccontinue,\u201d \u201cestimate,\u201d \u201cplan,\u201d \u201cpotential,\u201d \u201cpredict,\u201d \u201cproject,\u201d \u201cwill,\u201d \u201ccan have,\u201d \u201clikely,\u201d \u201cshould,\u201d \u201cwould,\u201d \u201ccould,\u201d and other words and terms of similar meaning\u00a0identify forward-looking statements.\u00a0Actual results may differ materially from those indicated by such forward-looking statements as a result of various factors, including, but not limited to, risks related to: our financial condition and need for additional capital; our development work; cost and success of our product development activities and preclinical and clinical trials; commercializing any approved pharmaceutical product developed using our AI platform technology, including the rate and degree of market acceptance of our product candidates; our dependence on third parties including for conduct of clinical testing and product manufacture; our inability to enter into partnerships; government regulation; protection of our intellectual property rights; employee matters and managing growth; our ADSs and ordinary shares,\u00a0the impact of international economic, political, legal, compliance, social and business factors, including inflation, and the effects on our\u00a0business from other significant geopolitical and macro-economic events;\u00a0and other uncertainties affecting our business operations and financial condition.\u00a0For a further discussion of these risks, please refer to the risk factors included in our most recent Annual Report on Form 20-F\u00a0and other filings\u00a0with the US Securities and Exchange Commission (SEC), which are available at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=emRw-qP6659RdXEvxdDwV8-EGw0HRxBKIQj69hP7SZhaguqFclfp_WPaJjUDu8tBCRRqVy7WOXjvFeqOBriaCvuulVaEeTplaeTBMaCYzPCxq_M-JnAAYfD--lTHMR7CUrup2X6P0YKjPIfOLaeSEq4IaiK0NSzsa6xrKnShaYlOd1V9vTcMfv6ObduTFL-7FWfxmH8Emf_a98zG2g6gPIRn5r91c_t0-akYVt1QEhI=\" rel=\"nofollow\" target=\"_blank\" title=\"\"><b>www.sec.gov<\/b><\/a>.\u00a0We do not assume any obligation to update any forward-looking statements except as required by law.\u00a0<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/MDA3YjdkNGItZjRkMC00NjVhLTgxMjEtMjQxOGE5ZDlkN2Q2LTEyNjM2NDAtMjAyNi0wMy0zMC1lbg==\/tiny\/Evaxion.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Using its pioneering AI-platform, AI-Immunology&#x2122;, Evaxion has, in collaboration with the Gates Foundation, developed novel design concepts for polio vaccines potentially superior to those currently used The AI-Immunology&#x2122; concepts include hybrid capsid designs and de novo designed B-cell antigen approaches Despite polio vaccines being available for decades, the highly infectious viral disease continues to pose [&#8230;]\n","protected":false},"author":1,"featured_media":85254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-79009","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress\" \/>\n<meta property=\"og:description\" content=\"Using its pioneering AI-platform, AI-Immunology&#x2122;, Evaxion has, in collaboration with the Gates Foundation, developed novel design concepts for\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-30T12:05:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml-eu.globenewswire.com\/media\/MDA3YjdkNGItZjRkMC00NjVhLTgxMjEtMjQxOGE5ZDlkN2Q2LTEyNjM2NDAtMjAyNi0wMy0zMC1lbg==\/tiny\/Evaxion.png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress\",\"datePublished\":\"2026-03-30T12:05:26+00:00\",\"dateModified\":\"2026-03-30T12:05:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/\"},\"wordCount\":859,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/\",\"name\":\"Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-03-30T12:05:26+00:00\",\"dateModified\":\"2026-03-30T12:05:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/","og_locale":"en_US","og_type":"article","og_title":"Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress","og_description":"Using its pioneering AI-platform, AI-Immunology&#x2122;, Evaxion has, in collaboration with the Gates Foundation, developed novel design concepts for","og_url":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-03-30T12:05:26+00:00","og_image":[{"url":"https:\/\/ml-eu.globenewswire.com\/media\/MDA3YjdkNGItZjRkMC00NjVhLTgxMjEtMjQxOGE5ZDlkN2Q2LTEyNjM2NDAtMjAyNi0wMy0zMC1lbg==\/tiny\/Evaxion.png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress","datePublished":"2026-03-30T12:05:26+00:00","dateModified":"2026-03-30T12:05:26+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/"},"wordCount":859,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/","url":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/","name":"Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-03-30T12:05:26+00:00","dateModified":"2026-03-30T12:05:26+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/evaxion-to-present-novel-ai-based-polio-vaccine-design-concepts-at-the-world-vaccine-congress\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Evaxion to present novel AI-based polio vaccine design concepts at the World Vaccine Congress"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/79009","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=79009"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/79009\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/85254"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=79009"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=79009"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=79009"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}